Delivery Order SPE2DB20D2104-SPE2DB22FS36K
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,730.56, is for the supply of Sucralfate 1 gm/10 ml suspension in 420 ml bottles. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,663,747 units of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. The contract has a firm fixed price of $1,649.74 and a completion date of September 4, 2024. This contract is not a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,586.16, is for the supply of Sucralfate 1 GM/10 ML Suspension in 420 ML bottles. The order has a firm fixed price pricing type and an ultimate completion date of September 4, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded numerous federal contracts and indefinite delivery...
- This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,929.19 contract is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities to support federal healthcare programs. The contract has an ultimate completion date of April 20, 2023 and was not designated with any set-aside requirements, indicating open competition....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $2,227.03, is for the supply of 4,565,891,255 units of Sucralfate 1 GM/10 ML Suspension in 420ML containers. The contract has an ultimate completion date of September 23, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
- The federal contract award is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $1,455.06 with a Firm Fixed Price pricing type. The period of performance runs through May 16, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, ID SPE2DX15D1022|SPE2DX24FVDJL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,335.78 firm fixed-price delivery order is for the supply of Sucralfate 1 GM/10 ML Suspension in 420 ML containers, with a completion date of February 8, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order under Contract SPE2DX15D1053 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,562,782,604 units of Sucralfate 1 GM/10 ML Suspension in 420 ML bottles, with a firm fixed price ceiling of $3,274.80. The contract has an ultimate completion date of November 13, 2023. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,249.41 firm fixed-price contract is for the supply of Sucralfate 1 GM/10 ML Suspension 420 ML, a medical product used in the treatment of various gastrointestinal conditions. The contract does not have a set-aside designation, indicating open competition. It is associated with a larger Indefinite...
- This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Sucralfate 1 GM/10 ML Suspension in 420 ML bottles. The delivery order has a firm fixed price of $4,547.57 and a completion date of January 11, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and has previously received numerous federal contracts from DLA to supply...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FS36KDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Sucralfate 1 GM/10 ML suspension in 420 ML containers. The $2,710.43 firm fixed price contract has an ultimate completion date of April 11, 2022. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products and supplies to federal agencies, with a significant focus on supporting the healthcare needs of the Department of Defense and Department of Veterans Affairs. The company holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering essential pharmaceutical and medical commodities to military treatment facilities globally. This specific delivery order is issued under that larger IDC contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 4/8/22 |